Concepedia

Author

Maria Palmisano

Bristol-Myers Squibb (United States)ORCID

Also Known As

M PALMISANO, M Palmisano, M. Palmisano, Maria Palmisano, Palmisano M

106

Publications

2.1K

Citations

26

H-Index

53

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Bristol-Myers Squibb (Switzerland)University of MichiganSanofi (United States)Bristol-Myers Squibb (Germany)
MP

About

Maria Palmisano is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

14

16

468

2

Engineering

1

1

60

3

Natural Sciences

1

1

40

4

Public Health

1

1

24

5

Anesthesia

1

1

32

Maria Palmisano

×

49

Publications

1.6K

Citations

24

H-Index

YearCitations

JNK inhibition reduces lung remodeling and pulmonary fibrotic systemic markers

Jos van der Velden, Ying Ye, James D. Nolin,

Clinical and Translational Medicine

2016

118

Albumin-bound nanoparticle (nab) paclitaxel exhibits enhanced paclitaxel tissue distribution and tumor penetration

Nianhang Chen, Carrie Baker Brachmann, Xiping Liu,

Cancer Chemotherapy and Pharmacology

2015

116

Pharmacokinetics and tolerability of formoterol in healthy volunteers after a single high dose of Foradil dry powder Inhalation via aerolizer TM

J. B. Lecaillon, G. Kaiser, Maria Palmisano,

European Journal of Clinical Pharmacology

1999

81

Cereblon modulator iberdomide induces degradation of the transcription factors Ikaros and Aiolos: immunomodulation in healthy volunteers and relevance to systemic lupus erythematosus

Peter Schäfer, Ying Ye, Lei Wu,

Annals of the Rheumatic Diseases

2018

77

Absorption, Metabolism, and Excretion, In Vitro Pharmacology, and Clinical Pharmacokinetics of Ozanimod, a Novel Sphingosine 1-Phosphate Receptor Modulator

Sekhar Surapaneni, Usha Yerramilli, April Bai,

Drug Metabolism and Disposition

2021

70

Distinct biodistribution of doxorubicin and the altered dispositions mediated by different liposomal formulations

Ruijuan Luo, Yan Li, Miao He,

International Journal of Pharmaceutics

2017

64

Reappraisal of anticancer nanomedicine design criteria in three types of preclinical cancer models for better clinical translation

Xin Luan, Hebao Yuan, Yudong Song,

Biomaterials

2021

60

Effect of renal impairment on the pharmacokinetics and pharmacodynamics of desirudin

Gilbert Lefèvre, Martine Duval, Sonia Gauron,

Clinical Pharmacology & Therapeutics

1997

52

Human Dermal Safety Studies with Eflornithine HCl 13.9% Cream (Vaniqa), a Novel Treatment for Excessive Facial Hair

Janet G. Hickman, Ferdinand Huber, Maria Palmisano

Current Medical Research and Opinion

2001

51

Population pharmacokinetics of pomalidomide

Yan Li, Yejun Xu, Liangang Liu,

The Journal of Clinical Pharmacology

2015

46

Page 1